ARG1, an enzyme that is expressed primarily by neutrophils and M2 macrophages with immunosuppressive activity21 was significantly upregulated by trastuzumab in tumour tissue only in non-responders (Figure S8), suggesting that circulating neutrophil counts reflect the immunosuppressive status of the tumour microenvironment. Here, ARG1 is linked to neoplasm.